Education
About Us
Working with TipRanks
Follow Us
Crescita Therpeutc (TSE:CTX)
:CTX
RESEARCH TOOLSreports
Total Valuation
Crescita Therpeutc has a market cap or net worth of C$9.37M. The enterprise value is C$7.03M.
Market CapC$9.37M
Enterprise ValueC$7.03M
Share Statistics
Crescita Therpeutc has 18,939,262 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding18,939,262
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Crescita Therpeutc’s return on equity (ROE) is -0.17 and return on invested capital (ROIC) is -19.12%.
Return on Equity (ROE)-0.17
Return on Assets (ROA)-0.13
Return on Invested Capital (ROIC)-19.12%
Return on Capital Employed (ROCE)-0.20
Revenue Per Employee244.75K
Profits Per Employee-34.38K
Employee Count80
Asset Turnover0.90
Inventory Turnover2.46
Valuation Ratios
The current PE Ratio of Crescita Therpeutc is -4.06. Crescita Therpeutc’s PEG ratio is -0.09.
PE Ratio-4.06
PS Ratio0.00
PB Ratio0.65
Price to Fair Value0.71
Price to FCF-10.93
Price to Operating Cash Flow-13.39
PEG Ratio-0.09
Income Statement
In the last 12 months, Crescita Therpeutc had revenue of 19.58M and earned -2.75M in profits. Earnings per share was -0.14.
Revenue19.58M
Gross Profit9.61M
Operating Income-3.21M
Pretax Income-2.76M
Net Income-2.75M
EBITDA-1.29M
Earnings Per Share (EPS)-0.14
Cash Flow
In the last 12 months, operating cash flow was 2.73M and capital expenditures -2.10M, giving a free cash flow of 628.00K billion.
Operating Cash Flow2.73M
Free Cash Flow628.00K
Free Cash Flow per Share0.03
Dividends & Yields
Crescita Therpeutc pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.16
52-Week Price Change-3.85%
50-Day Moving Average0.53
200-Day Moving Average0.57
Relative Strength Index (RSI)47.67
Average Volume (3m)10.95K
Important Dates
Crescita Therpeutc upcoming earnings date is Aug 6, 2025, TBA (Confirmed).
Last Earnings DateMay 14, 2025
Next Earnings DateAug 6, 2025
Ex-Dividend Date―
Financial Position
Crescita Therpeutc as a current ratio of 2.77, with Debt / Equity ratio of 7.65%
Current Ratio2.77
Quick Ratio2.04
Debt to Market Cap0.00
Net Debt to EBITDA6.56
Interest Coverage Ratio-49.46
Taxes
In the past 12 months, Crescita Therpeutc has paid -14.00K in taxes.
Income Tax-14.00K
Effective Tax Rate<0.01
Enterprise Valuation
Crescita Therpeutc EV to EBITDA ratio is -2.13, with an EV/FCF ratio of 1.78.
EV to Sales0.14
EV to EBITDA-2.13
EV to Free Cash Flow1.78
EV to Operating Cash Flow1.01
Balance Sheet
Crescita Therpeutc has C$9.27M in cash and marketable securities with C$834.00K in debt, giving a net cash position of -C$8.44M billion.
Cash & Marketable SecuritiesC$9.27M
Total DebtC$834.00K
Net Cash-C$8.44M
Net Cash Per Share-C$0.45
Tangible Book Value Per ShareC$0.73
Margins
Gross margin is 56.03%, with operating margin of -16.42%, and net profit margin of -14.04%.
Gross Margin56.03%
Operating Margin-16.42%
Pretax Margin-14.12%
Net Profit Margin-14.04%
EBITDA Margin-6.57%
EBIT Margin-13.78%
Analyst Forecast
The average price target for Crescita Therpeutc is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast1.14%
EPS Growth Forecast-36.66%